IART

INTEGRA LIFESCIENCES HOLDINGS CORP

IART · CIK 917520 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$1.6B
20182025
Net Income−$0.5B
20182025
Operating CF$0.1B
20182025
Free Cash Flow−$0.0B
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$1.6B$1.6B$1.5B$1.6B$1.5B$0.4B$0.4B$0.4B
Cost of Revenue$0.8B$0.7B$0.7B$0.6B$0.6B$0.5B$0.6B$0.6B
Gross Profit—————$0.2B$0.2B$0.2B
R&D Expense———————$0.1B
SG&A Expense$0.7B$0.7B$0.7B$0.6B$0.6B$0.6B$0.7B$0.7B
Operating Income$-0.5B$0.0B$0.1B$0.2B$0.2B$0.2B$0.1B$0.1B
Net Income$-0.5B$-0.0B$0.1B$0.2B$0.2B$0.1B$0.0B$0.0B
EPS (Basic)$-6.74$-0.09$0.85$2.18$2.00$1.10$0.18$0.29
EPS (Diluted)$-6.74$-0.09$0.84$2.16$1.98$1.09$0.18$0.29

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$3.6B$4.0B$3.8B$3.9B$3.8B$3.6B$3.3B$3.1B
Current Assets$1.2B$1.1B$1.1B$1.2B$1.2B$1.2B$0.9B$0.8B
Cash & Equivalents$0.2B$0.2B$0.3B$0.5B$0.5B$0.5B$0.2B$0.1B
Total Liabilities$2.6B$2.5B$2.2B$2.1B$2.1B$2.1B$1.9B$1.7B
Current Liabilities$0.5B$0.9B$0.3B$0.3B$0.3B$0.4B$0.3B$0.3B
Stockholders' Equity$1.0B$1.5B$1.6B$1.8B$1.7B$1.5B$1.4B$1.4B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.1B$0.1B$0.1B$0.3B$0.3B$0.2B$0.2B$0.2B
Investing Cash Flow$-0.1B$-0.4B$-0.1B$-0.1B$-0.2B$-0.1B$-0.2B$-0.0B
Capital Expenditures$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B$0.1B$0.1B
Financing Cash Flow$0.0B$0.2B$-0.2B$-0.3B$-0.1B$0.1B$-0.0B$-0.2B
← Companies